Navigation Links
Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential

se" by the Principal Investigator, Dr. Cohen. It is expected that detailed results of the study will be published in a scientific journal.

About AVANT Immunotherapeutics, Inc.

AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. AVANT has three products on the market and four of AVANT's products are in clinical development. AVANT's pipeline includes products for travelers' vaccines and global health needs based on AVANT's oral, rapid-protecting, single-dose and temperature-stable vaccine technology.

Additional information on AVANT Immunotherapeutics, Inc. can be obtained through its site on the World Wide Web: http://www.avantimmune.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that are subject to a variety of risks and uncertainties and reflect AVANT's current views with respect to future events and financial performance. There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by AVANT. These factors include, but are not limited to: (1) the integration of multiple technologies and programs; (2) the ability to adapt AVANT's vectoring systems to develop new, safe and effective orally administered vaccines against anthrax and plague or other any other microbes used as bioweapons and other disease causing agents; (3) the ability to successfully complete product research and further development, including animal, pre-clinical and clinical studies, and commercialization of CholeraGarde(R) (Peru-15), Ty800, ETEC E. coli vaccine, VLPs and other products and AVANT's expectations regarding market growth; (4) the cost, timing, scope and results of ongoing safety and efficacy trials of CholeraGarde(R) (Peru-15), Ty800, ETEC E. coli vaccine and other preclinica
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
9. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
10. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
11. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference

Post Your Comments:
(Date:11/6/2009)...re/ -- Trius Therapeutics, Inc. announced today th...-1 with the U.S. Securities and Exchange Commissio...ring of shares of its common stock. All shares of ...e offered by the Company. ,, Credit Suisse Secu...nager, Piper Jaffray & Co. is acting as co-lea...
(Date:11/6/2009)...ewswire-FirstCall/ -- Roper Industries, Inc. (NY...finitive agreement to acquire Verathon, Inc., a le...e Verathon Board of Directors has approved the tra...egulatory approvals and closing conditions, includ...closing to be completed in early December. ,, ...
(Date:11/6/2009)...Newswire-FirstCall/ -- Derma Sciences, Inc. (O...ound care products, announced plans to release its...y, November 16, 2009. The Company will hold a conf...t 11:00 am EST. Interested parties should call (86...ional), with passcode 81416481 to access the call....
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 1GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 2GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 3Man Discovers Cure for Excessive Sweating 48990 1Man Discovers Cure for Excessive Sweating 48990 2New Source of Information on Pulmonary Hypertension Medications 48988 1New Source of Information on Pulmonary Hypertension Medications 48988 2
...entific,data submitted in recent months to the U.S...n for the March 13th Oncologic Drugs Advisory Comm...-stimulating agents (ESAs) are,safe and effective ...chemotherapy- induced anemia (CIA). ESAs are an im...nly proven therapeutic alternative to blood,transf...
...gnificantly Improves Effectiveness of RNAi ..., March 10 Thermo Fisher,Scientific Inc. (NYSE: ...veloped a breakthrough gene-silencing tool that gr...gy and eliminates barriers associated with,previou...ed to accelerate,research and drug discovery in ma...
Other Medicine Technology:Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 2Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 3Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 4Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 5Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 6Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 2Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 3
(Date:11/8/2009)... 3D Global Solutions is pleased to a...aging the proposal effort for ReSound who recently...Hearing Aid contract. The award includes not only ...nt of Defense and other federal agencies. , ..., 2009 -- 3D Global Solutions is pleased to announ...
(Date:11/8/2009)... Men’s Health Network (MHN) ur...risks, especially those linked to exposure to chem...ry service. Bladder cancer is one of those cancers...ecially those who once smoked or currently smoke c...C (PRWEB) November 8, 2009 -- Men’s Health N...
(Date:11/8/2009)...NGTON, Nov. 7 Today, th...s, Kaptur, Dahlkemper, Smith, Ellsworth and Lipins...erica Act" (H.R. 3962). The amendment maintains th... abortion and for benefits packages that include a... who receive affordability credits and those who d...
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
(Date:11/8/2009)...NGTON, Nov. 8 Pharmaceu...) Senior Vice President Ken Johnson released the f... reform bill: ,, "We are disappointed, but not ...by millions of hardworking Americans as well as ne...esentatives who voted against the bill. ,, "Whi...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
..., symptoms of schizophrenia can be relieved by mus...llege London conducted a study in 4 hospitals and ... patients when they were encouraged to express the...d when people are fairly stable," said Dr Mike Cra...
...nly prescribed invasive test performed during preg... while doctors// recommend them based on guideline...ynecologists. These guidelines stem from past rese...ases the rate of miscarriage by 0.5% or 1 in 200 p...
...t to seek medical treatment to correct the malady,...y of 10,900 men found erectile problems affected 5...laysia and Japan, the South China Morning Post sai...id just 36 percent of them seek medical help. ...
... Alois Alzheimer presented a paper entitled "Regar...heimer's colleagues did not immediately recognise ..., the name of Alois Alzheimer (1864-1915) is known...after the scientist. Worldwide over 20 million are...
...f company and sad and lonely at the end of a day g...e cortisol in their blood the next morning,// rese... National Academy of Sciences USA. Hormone co...n a radical study the first of its kind, daily exp...
... breasts pierced for her 18th birthday suffered ne... doctors to surgically remove her left// breast. S...n right up to Stephanie Edington’s collar bone las...with gas gangrene or necrotizing fasciitis a very ...
Other Medicine News:Health News:Amniocentesis Safer for Pregnant Women 2Health News:Alzheimer's - From Curiosity To Worldwide Disease 2
Soflens66 Toric
Acuvue Toric
Binocular Loupe C 2.3 x 340mm (13in) with Case
Binocular Loupe C 2.3 x 340 K with Case
Medicine Products: